Bruker Corporation
BRKR
$44.96
-$0.60-1.32%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 14.64% | 16.37% | 17.42% | 5.31% | 21.69% |
| Total Other Revenue | -- | -- | -- | -- | 111.29% |
| Total Revenue | 14.64% | 16.37% | 17.42% | 5.31% | 20.62% |
| Cost of Revenue | 14.50% | 21.93% | 18.07% | 11.34% | 22.59% |
| Gross Profit | 14.78% | 11.17% | 16.77% | -0.14% | 18.79% |
| SG&A Expenses | 17.98% | 28.96% | 24.34% | 19.78% | 25.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -861.11% | 278.13% | 160.00% | 57.14% | 5.88% |
| Total Operating Expenses | 14.53% | 27.14% | 21.62% | 14.86% | 24.42% |
| Operating Income | 15.19% | -34.00% | -10.23% | -37.03% | 4.64% |
| Income Before Tax | -77.41% | -53.89% | -69.50% | -33.08% | 98.60% |
| Income Tax Expenses | 9.70% | -51.95% | -19.10% | -33.78% | 58.55% |
| Earnings from Continuing Operations | -93.21% | -54.57% | -86.85% | -32.82% | 108.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -122.22% | 200.00% | -- | -22.22% | 200.00% |
| Net Income | -93.33% | -53.58% | -86.69% | -33.46% | 110.99% |
| EBIT | 15.19% | -34.00% | -10.23% | -37.03% | 4.64% |
| EBITDA | 20.72% | -12.76% | 8.72% | -24.54% | 11.91% |
| EPS Basic | -93.60% | -55.07% | -86.74% | -32.72% | 113.32% |
| Normalized Basic EPS | 12.74% | -39.31% | -10.60% | -26.67% | 5.68% |
| EPS Diluted | -93.58% | -55.00% | -87.15% | -32.69% | 112.72% |
| Normalized Diluted EPS | 12.82% | -39.22% | -10.41% | -26.61% | 5.90% |
| Average Basic Shares Outstanding | 4.19% | 3.34% | 0.41% | -1.09% | -1.09% |
| Average Diluted Shares Outstanding | 4.11% | 3.19% | 0.20% | -1.15% | -1.28% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 14.62% | 1.21% | 6.92% | 0.48% | -0.53% |
